Table 1.
Clinical, biochemical characteristics and radiation planning parameters of patients enrolled in this study
| Variables | n |
|---|---|
| Clinical and biochemical characteristics | |
| Sex | |
| Male | 80 (74.07%) |
| Female | 28 (25.93%) |
| Age (years) | |
| Median | 54 |
| Range | 37–77 |
| Underlying liver disease | |
| Hepatitis B | 97 (89.81%) |
| Hepatitis C | 7 (6.48%) |
| Alcoholic hepatitis | 3 (2.78%) |
| None | 1 (0.93%) |
| Maximum tumor diameter (cm) | |
| Median | 2.3 |
| Range | 0.7–4.9 |
| AFP (ng/ml) a | |
| Median | 33.13 |
| Range | 0.8–7896 |
| Child-Pugh score | |
| 5 | 97 (89.81%) |
| 6 | 11 (10.19%) |
| ALBI grade | |
| Grade 1 | 34 (31.48%) |
| Grade 2 | 74 (68.52%) |
| WBC count (×109/L) | |
| Median | 4.86 |
| Range | 1.53–9.4 |
| PLT count (×109/L) | |
| Median | 118 |
| Range | 50–283 |
| Radiation planning parameters | |
| Isodose line of maximum dose | |
| Median (range, %) | 72 (60–86) |
| Residual normal liver volume | |
| Median (range, cm3) | 1324 (834–2493) |
| Mean dose of whole liver volume minus GTV | |
| Median (range, Gy) | 9.07 (4.04–12.05) |
| Dose received by volume of liver | |
| D700c | 4.99 (1.40–13.50) |
| BED10b of Plan target volume (PTV) | |
| Median (range, Gy) | 100 (76.8–102.6) |